Beyond the API: Mapping the Secondary Patent Thicket to Forecast Generic Entry
In the high-stakes world of pharmaceutical innovation, the race to bring a new drug to market is more complex—and more strategic—than ever before. While many focus on the primary patent protecting the active pharmaceutical ingredient (API), a deeper la…
Beyond the API: Mapping the Secondary Patent Thicket to Forecast Generic Entry Read Post »
